Form 8-K - Current report:
SEC Accession No. 0001104659-22-119520
Filing Date
2022-11-16
Accepted
2022-11-16 16:01:27
Documents
14
Period of Report
2022-11-16
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2230653d5_8k.htm   iXBRL 8-K 47161
2 EXHIBIT 3.1 tm2230653d5_ex3-1.htm EX-3.1 21353
3 EXHIBIT 3.2 tm2230653d5_ex3-2.htm EX-3.2 88468
  Complete submission text file 0001104659-22-119520.txt   361810

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA logc-20221116.xsd EX-101.SCH 3033
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE logc-20221116_lab.xml EX-101.LAB 34476
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE logc-20221116_pre.xml EX-101.PRE 22595
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2230653d5_8k_htm.xml XML 3831
Mailing Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421
Business Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421 617-245-0399
LogicBio Therapeutics, Inc. (Filer) CIK: 0001664106 (see all company filings)

IRS No.: 471514975 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38707 | Film No.: 221395139
SIC: 2836 Biological Products, (No Diagnostic Substances)